Genrix (shanghai) Biopharmaceutical Co., Ltd.

This study tests whether a new drug called GR1803 works better than the standard treatment daratumumab (combined with pomalidomide and dexamethasone) for people with multiple myeloma that has returned or stopped responding after 1 to 3 prior treatments. About 358 adults with this…

This early-stage trial tests a new drug called GR1803 in 44 people with systemic lupus erythematosus (SLE), an autoimmune disease. The goal is to see if the drug is safe and can help control lupus symptoms. Participants must have moderate to severe disease and be on standard trea…

This study tests an injection called GR1802 for people with seasonal allergies (hay fever) that are not well controlled by standard treatments. About 150 adults will receive either the drug or a placebo, along with their usual allergy medications. The goal is to see if the inject…

This early-stage study is testing a new drug, GR2303, in 64 healthy adults to see if it is safe and how the body handles it. Participants are randomly assigned to receive either the drug or a placebo. The study does not aim to treat any disease, but to gather important safety and…